Boehringer Ingelheim’s Uli Broedl, senior vice president and head of global clinical development and operations, discusses the company’s One Medicine Platform, partnership with Veeva, and how a platform approach aligns with their guiding principle to transform patients’ lives for generations.
Veeva - BI - In Vivo Article v2 no front pageLearn more about Boehringer Ingelheim’s partnership with Veeva or read in ACRP how they are unifying clinical to improve patient outcomes.